Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.24p
   
  • Change Today:
      0.000p
  • 52 Week High: 1.22p
  • 52 Week Low: 0.20p
  • Currency: UK Pounds
  • Shares Issued: 2,148.96m
  • Volume: 1,740,479
  • Market Cap: £5.05m
  • Beta: 0.00

Monday broker round-up

By Caoimhe Toman

Date: Monday 11 Jun 2018

LONDON (ShareCast) - (Sharecast News) - Rio Tinto: Deutsche Bank downgrades to hold with a target price of 4,700p.
Applegreen: Berenberg reiterates buy with a target price of 600p.

Inmarsat: RBC Capital Markets reiterates outperform with a target price of 850p.

Just Eat: RBC Capital Markets reiterates outperform with a target price of 950p.

Experian: Deutsche Bank downgrades to hold with a target price of 1,800p.

European Metals & Mining: Deutsche Bank downgrades to hold with a target price of 4,700p.

BT Group: Deutsche Bank reiterates hold with a target price of 235p.

TalkTalk: Deutsche Bank reiterates buy with a target price of 180p.

Informa: Deutsche Bank reiterates buy with a target price of 955p.

Ocado Group: Goldman Sachs upgrades to buy with a target price of 1,160p.

Keywords Studios: Peel Hunt reiterates add with a target price of 1,900p.

Rentokil: HSBC upgrades to buy with a target price of 440p.

Sainsbury: Kepler Cheuvreux upgrades to buy with a target price of 345p.

Tesco: Kepler Cheuvreux reiterates buy with a target price of 261p.

Redcentric: Numis downgrades to add with a target price of 108p.

Mitie Group: Canaccord reiterates buy with a target price of 300p.

Playtech: Canaccord reiterates buy with a target price of 970p.

British American Tobacco: Citigroup downgrades to neutral with a target price of 3,900p.

GB Group: Citigroup downgrades to neutral with a target price of 560p.

Gem Diamonds: Citigroup upgrades to buy with a target price of 150p.

Kaz Minerals: Citigroup reiterates buy with a target price of 1,040p.

Evgen Pharma: Northland Capital Markets reiterates buy with a target price of 113p.

Astrazeneca: Berenberg reiterates buy with a target price of 6,200p.

NMC Health: Berenberg reiterates buy with a target price of 4,600p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.24p
Change Today 0.000p
% Change 0.00 %
52 Week High 1.22p
52 Week Low 0.20p
Volume 1,740,479
Shares Issued 2,148.96m
Market Cap £5.05m
Beta 0.00

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.27% below the market average44.27% below the market average44.27% below the market average44.27% below the market average44.27% below the market average
58.33% above the sector average58.33% above the sector average58.33% above the sector average58.33% above the sector average58.33% above the sector average
Price Trend
95.38% below the market average95.38% below the market average95.38% below the market average95.38% below the market average95.38% below the market average
87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average
Income Not Available
Growth
16.52% below the market average16.52% below the market average16.52% below the market average16.52% below the market average16.52% below the market average
31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average

Theracryf Dividends

No dividends found

Trades for 09-May-2025

Time Volume / Share Price
14:24 5,000 @ 0.23p
13:29 109,301 @ 0.23p
09:30 1,511,364 @ 0.26p
08:35 3,703 @ 0.27p
08:08 111,111 @ 0.26p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page